CTBP1 and exocrine pancreatic carcinoma: The rescue assays showed that the inhibiting effects of CTBP1-AS2 knockdown on pancreatic carcinoma cell proliferation, migration, invasion and apoptosis could be reversed by USP22 overexpression.